{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:45:15Z","timestamp":1792629915950,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Rheumatoid arthritis (RA) is a chronic inflammatory disease that primarily affects the joints but also has extra-articular manifestations. Extra-articular manifestations (EAMs) in RA encompass a wide range of clinical findings that may significantly affect patients\u2019 quality of life. This study aimed to compare daily life, social function, and work productivity between RA patients with and without EAMs. In this study, we aimed to determine the differences in daily life, social life, and work between patients with and without EAM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This cross-sectional and observational study included 402 RA patients (2010 ACR-EULAR). EAM was defined as systemic symptoms and organ involvement occurring outside of the joint findings caused by RA. The presence of EAM was grouped as symptomatic\/asymptomatic. Patients were evaluated once during the study period in an outpatient setting. Patients completed the Health Assessment Questionnaire (HAQ), Short Form-36 (SF-36), and Work Productivity and Activity Impairment: General Health (WPAI: GH) forms under clinician observation. Continuous variables were compared using the Mann\u2013Whitney U test and Independent Samples T-test, while Fisher\u2019s exact test or chi-square test was used for categorical variables. The significance level was set at 5% (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study included 402 patients. 325 (80.8%) were female, with a median (IQR) age of 56 (47\u201364.25) and a mean\u00b1standard deviation (SD) disease duration of 9.7\u2009\u00b1\u20098.6 years. EAM was present in 200 patients. Patients were classified as having symptomatic EAM (sEAM) (n\u2009=\u200981), asymptomatic EAM (asEAM) (n\u2009=\u2009119), and no EAM (n\u2009=\u2009202). The median age was 60 (54.5\u201367), and the median age at diagnosis was 49 (39.5\u201358) in the sEAM group, which had the highest values (p:&lt;0.001 and p:0.003, respectively). Peripheral neuropathy detected in 24 (29.6%) patients was the most common symptomatic EAM, while keratoconjunctivitis sicca detected in 44 (36.9%) patients was the most common asymptomatic EAM. In sEAM patients, HAQ mean\u2009\u00b1\u2009SD was 0.92\u2009\u00b1\u20090.73, while in non-EAM patients it was 0.68\u2009\u00b1\u20090.65, p\u2009=\u20090.021. In SF-36 results, physical function, social function, role physical, vitality, and mental health were statistically significantly lower in patients with sEAM compared to other groups. The percentage of working patients was higher at 28.2% in those without EAM, p:0.010. Absenteeism, mean\u2009\u00b1\u2009SD, was higher in the sEAM group at 12.8\u2009\u00b1\u200928.1, p: 0.037, and activity impairment was also higher in sEAMs at mean\u2009\u00b1\u2009SD 44.2\u2009\u00b1\u200929.1, p:0.025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Regardless of RA disease activity, patients with sEAM experience negative impacts on both their daily and social lives as well as their work life. Symptomatic EAMs are associated with significant impairment in quality of life and work productivity, independent of traditional disease activity measures. Clinicians should therefore systematically assess and manage these manifestations as an integral component of RA care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42358-026-00569-5","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T09:11:52Z","timestamp":1784970712000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The effect of symptomatic extra-articular manifestations of rheumatoid arthritis on disease activity and patient-reported outcomes: a cross-sectional and observational study"],"prefix":"10.1186","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0923-5148","authenticated-orcid":false,"given":"Ahmet","family":"Oru\u00e7","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7605-1301","authenticated-orcid":false,"given":"Hasan","family":"Sat\u0131\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4973-8804","authenticated-orcid":false,"given":"Merve","family":"Oru\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2523-1695","authenticated-orcid":false,"given":"Reyhan","family":"Bilici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6244-9362","authenticated-orcid":false,"given":"Abdurrahman","family":"Tufan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7203-3934","authenticated-orcid":false,"given":"Mehmet Akif","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"issue":"9746","key":"569_CR1","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","volume":"376","author":"DL Scott","year":"2010","unstructured":"Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010;376(9746):1094\u2013108.","journal-title":"Lancet"},{"issue":"4","key":"569_CR2","doi-asserted-by":"publisher","first-page":"212","DOI":"10.4081\/reumatismo.2018.1106","volume":"70","author":"E Marcucci","year":"2018","unstructured":"Marcucci E, Bartoloni E, Alunno A, Leone MC, Cafaro G, Luccioli F, et al. Extra-articular rheumatoid arthritis. Reumatismo. 2018;70(4):212\u201324.","journal-title":"Reumatismo"},{"key":"569_CR3","doi-asserted-by":"crossref","unstructured":"Mitrovic J, Hrkac S, Tecer J, Golob M, Ljilja Posavec A, Kolar Mitrovic H et al. Pathogenesis of extraarticular manifestations in rheumatoid arthritis-a comprehensive review. Biomedicines. 2023;11(5).","DOI":"10.3390\/biomedicines11051262"},{"issue":"2","key":"569_CR4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/03009740310004621","volume":"33","author":"C Turesson","year":"2004","unstructured":"Turesson C, Jacobsson LT. Epidemiology of extra-articular manifestations in rheumatoid arthritis. Scand J Rheumatol. 2004;33(2):65\u201372.","journal-title":"Scand J Rheumatol"},{"issue":"8","key":"569_CR5","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1136\/ard.62.8.722","volume":"62","author":"C Turesson","year":"2003","unstructured":"Turesson C, O\u2019Fallon WM, Crowson CS, Gabriel SE, Matteson EL. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis. 2003;62(8):722\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"569_CR6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.rbr.2014.03.025","volume":"54","author":"I Roma","year":"2014","unstructured":"Roma I, de Almeida ML, Mansano Nda S, Viani GA, de Assis MR, Barbosa PM. [Quality of life in adults and elderly patients with rheumatoid arthritis]. Rev Bras Reumatol. 2014;54(4):279\u201386.","journal-title":"Rev Bras Reumatol"},{"issue":"1","key":"569_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s41927-023-00365-4","volume":"7","author":"L Kirkeskov","year":"2023","unstructured":"Kirkeskov L, Bray K. Employment of patients with rheumatoid arthritis - a systematic review and meta-analysis. BMC Rheumatol. 2023;7(1):41.","journal-title":"BMC Rheumatol"},{"issue":"1","key":"569_CR8","first-page":"157","volume":"58","author":"R Martinec","year":"2019","unstructured":"Martinec R, Pinjatela R, Balen D. Quality of Life in Patients with Rheumatoid Arthritis - a Preliminary Study. Acta Clin Croat. 2019;58(1):157\u201366.","journal-title":"Acta Clin Croat"},{"issue":"Suppl 6","key":"569_CR9","doi-asserted-by":"publisher","first-page":"vi5","DOI":"10.1093\/rheumatology\/kes279","volume":"51","author":"J Kay","year":"2012","unstructured":"Kay J, Upchurch KS. ACR\/EULAR 2010 rheumatoid arthritis classification criteria. Rheumatology (Oxford). 2012;51(Suppl 6):vi5\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"569_CR10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s13075-016-1151-6","volume":"18","author":"E Nikiphorou","year":"2016","unstructured":"Nikiphorou E, Radner H, Chatzidionysiou K, Desthieux C, Zabalan C, van Eijk-Hustings Y, et al. Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature. Arthritis Res Ther. 2016;18(1):251.","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"569_CR11","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/rheumatology\/kev395","volume":"55","author":"M Hifinger","year":"2016","unstructured":"Hifinger M, Putrik P, Ramiro S, Keszei AP, Hmamouchi I, Dougados M, et al. In rheumatoid arthritis, country of residence has an important influence on fatigue: results from the multinational COMORA study. Rheumatology (Oxford). 2016;55(4):735\u201344.","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 11","key":"569_CR12","first-page":"S4","volume":"63","author":"L Maska","year":"2011","unstructured":"Maska L, Anderson J, Michaud K. Measures of functional status and quality of life in rheumatoid arthritis: Health Assessment Questionnaire Disability Index (HAQ), Modified Health Assessment Questionnaire (MHAQ), Multidimensional Health Assessment Questionnaire (MDHAQ), Health Assessment Questionnaire II (HAQ-II), Improved Health Assessment Questionnaire (Improved HAQ), and Rheumatoid Arthritis Quality of Life (RAQoL). Arthritis Care Res (Hoboken). 2011;63(Suppl 11):S4\u201313.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"8","key":"569_CR13","first-page":"1528","volume":"35","author":"L Linde","year":"2008","unstructured":"Linde L, Sorensen J, Ostergaard M, Horslev-Petersen K, Hetland ML. Health-related quality of life: validity, reliability, and responsiveness of SF-36, 15D, EQ-5D [corrected] RAQoL, and HAQ in patients with rheumatoid arthritis. J Rheumatol. 2008;35(8):1528\u201337.","journal-title":"J Rheumatol"},{"key":"569_CR14","doi-asserted-by":"crossref","unstructured":"Looijen AEM, Snoeck Henkemans SVJ, van der Helm-van Mil AHM, Welsing PMJ, Koc GH, Luime JJ et al. Combining patient-reported outcome measures to screen for active disease in rheumatoid arthritis and psoriatic arthritis. RMD Open. 2024;10(4).","DOI":"10.1136\/rmdopen-2024-004687"},{"issue":"2","key":"569_CR15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.semarthrit.2014.05.001","volume":"44","author":"F Matcham","year":"2014","unstructured":"Matcham F, Scott IC, Rayner L, Hotopf M, Kingsley GH, Norton S, et al. The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: a systematic review and meta-analysis. Semin Arthritis Rheum. 2014;44(2):123\u201330.","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"569_CR16","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/rheumatology\/ker371","volume":"51","author":"LM Braakman-Jansen","year":"2012","unstructured":"Braakman-Jansen LM, Taal E, Kuper IH, van de Laar MA. Productivity loss due to absenteeism and presenteeism by different instruments in patients with RA and subjects without RA. Rheumatology (Oxford). 2012;51(2):354\u201361.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"569_CR17","doi-asserted-by":"publisher","first-page":"R177","DOI":"10.1186\/ar3141","volume":"12","author":"W Zhang","year":"2010","unstructured":"Zhang W, Bansback N, Boonen A, Young A, Singh A, Anis AH. Validity of the work productivity and activity impairment questionnaire\u2013general health version in patients with rheumatoid arthritis. Arthritis Res Ther. 2010;12(5):R177.","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"569_CR18","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1093\/rheumatology\/keq117","volume":"49","author":"EM Hensor","year":"2010","unstructured":"Hensor EM, Emery P, Bingham SJ, Conaghan PG, Consortium Y. Discrepancies in categorizing rheumatoid arthritis patients by DAS-28(ESR) and DAS-28(CRP): can they be reduced? Rheumatology (Oxford). 2010;49(8):1521\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"569_CR19","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van \u2018t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38(1):44\u20138.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"569_CR20","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.1007\/s10067-021-05664-0","volume":"40","author":"G Sanchez-Cardenas","year":"2021","unstructured":"Sanchez-Cardenas G, Contreras-Yanez I, Guaracha-Basanez G, Pacheco-Santiago LD, Mendez-Flores S, Barrera-Vargas A, et al. Cutaneous manifestations are frequent and diverse among patients with rheumatoid arthritis and impact their quality of life: a cross-sectional study in a cohort of patients with recent-onset disease. Clin Rheumatol. 2021;40(9):3581\u201390.","journal-title":"Clin Rheumatol"},{"issue":"4","key":"569_CR21","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.rdc.2017.06.005","volume":"43","author":"K DeQuattro","year":"2017","unstructured":"DeQuattro K, Imboden JB. Neurologic Manifestations of Rheumatoid Arthritis. Rheum Dis Clin North Am. 2017;43(4):561\u201371.","journal-title":"Rheum Dis Clin North Am"},{"issue":"5","key":"569_CR22","doi-asserted-by":"publisher","first-page":"501891","DOI":"10.1016\/j.reuma.2025.501891","volume":"21","author":"RE Ruiz-Lozano","year":"2025","unstructured":"Ruiz-Lozano RE, Prida-Espaillat LA, Moll-Auais RA, Ramos-Davila EM, Quiroga-Garza ME, Zhao A, et al. Ocular inflammatory manifestations in patients with rheumatoid arthritis. Reumatol Clin (Engl Ed). 2025;21(5):501891.","journal-title":"Reumatol Clin (Engl Ed)"},{"issue":"7","key":"569_CR23","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s10067-007-0804-x","volume":"27","author":"V Agarwal","year":"2008","unstructured":"Agarwal V, Singh R, Wiclaf, Chauhan S, Tahlan A, Ahuja CK, et al. A clinical, electrophysiological, and pathological study of neuropathy in rheumatoid arthritis. Clin Rheumatol. 2008;27(7):841\u20134.","journal-title":"Clin Rheumatol"},{"issue":"5","key":"569_CR24","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.berh.2007.05.007","volume":"21","author":"A Young","year":"2007","unstructured":"Young A, Koduri G. Extra-articular manifestations and complications of rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2007;21(5):907\u201327.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"569_CR25","doi-asserted-by":"publisher","first-page":"rkac071","DOI":"10.1093\/rap\/rkac071","volume":"6","author":"H Direskeneli","year":"2022","unstructured":"Direskeneli H, Karadag O, Ates A, Tufan A, Inanc N, Koca SS, et al. Quality of life, disease activity and preferences for administration routes in rheumatoid arthritis: a multicentre, prospective, observational study. Rheumatol Adv Pract. 2022;6(3):rkac071.","journal-title":"Rheumatol Adv Pract"}],"container-title":["Advances in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42358-026-00569-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-026-00569-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-026-00569-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:27:02Z","timestamp":1792628822000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42358-026-00569-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["569"],"URL":"https:\/\/doi.org\/10.1186\/s42358-026-00569-5","relation":{},"ISSN":["2523-3106"],"issn-type":[{"value":"2523-3106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were performed in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Permission for the study was obtained from Gazi University Clinical Research Ethics Committee with the meeting date of 07.08.2020 and decision number 497. Informed consent was obtained from all the participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"60"}}